Savient Wins Generic Restraining Order For Oxandrin
Keeping generic companies at bay, drug maker Savient Pharmaceuticals Inc. has won a temporary restraining order halting the sale of all generic forms of weight-gain drug Oxandrin in its patent infringement...To view the full article, register now.
Already a subscriber? Click here to view full article